From the NIH Director’s Blog, August 24, 2021
The Amazing Brain: Tracking Molecular Events with Calling Cards (Links to an external site)
Category: ICTS News
Too many research papers just languish on the shelf. These St. Louis scientists want to put them in action. (Links to an external site)
Investigators in the field of Dissemination & Implementation ask: How can we use what we already know to make people healthier?
The WashU Precision Health Experience
ICTS Associate Director Christina Gurnett, MD, PhD was the featured speaker at the July 8th NextGen Precision Health Discovery Series. She spoke about the Institute of Clinical and Translational Sciences Precision Health function, including efforts to integrate of genomic and electronic health record data, engage community and research participants through return of research results, and […]
Antibodies elicited by COVID-19 vaccination effective against delta variant (Links to an external site)
Findings help explain why vaccinated people at low risk during delta surge
Investigator uses ICTS resources for COVID-19 research and clinical trial efforts
The CTSA program was developed to accelerate new treatments from the lab to patients, enabled to a large extent by patients participating in and benefiting from clinical trials. Clinical trials provide that needed bridge from human subjects to hypotheses to treatments that can directly benefit human health. And, never has this connection been more critical […]
mRNA Vaccines May Pack More Persistent Punch Against COVID-19 Than Thought (Links to an external site)
Ganesh Babulal, PhD, featured in CLIC profile on CTSA program brain researchers (Links to an external site)
June is National Alzheimer’s and Brain Awareness month. Scientists supported by the CTSA Program are contributing important research to help patients with neurodegenerative diseases.
COVID-19 vaccine generates immune structures critical for lasting immunity (Links to an external site)
Vaccines likely induce strong, persistent immunity to COVID-19
Virus that causes COVID-19 can find alternate route to infect cells (Links to an external site)
COVID-19 drugs, vaccines still effective against mutating virus
Measuring the impact of science; How CTSAs use the Translational Science Benefits Model to show real world benefits
Challenge of measuring impact Government, non-profits, and organizations fund research with the ultimate goal of improving health and society. Yet measuring these long-term outcomes can be challenging, and research impact has traditionally been tied to quantitative productivity, like bibliometrics and grant funding, and not necessarily the broader impacts of research. For years, researchers lacked a […]